Stanley-Laman Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Stanley-Laman Group’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$34.8K	Hold	12,000	–	–	0.01%	281
2025 Q1	$11.8K	Hold	12,000	–	–	﹤0.01%	281
2024 Q4	$6K	Hold	12,000	–	–	﹤0.01%	282
2024 Q3	$44.8K	Hold	12,000	–	–	0.01%	289
2024 Q2	$67.2K	Hold	12,000	–	–	0.01%	269
2024 Q1	$62.9K	Hold	12,000	–	–	0.01%	246
2023 Q4	$62.8K	Hold	12,000	–	–	0.01%	230
2023 Q3	$189K	Hold	12,000	–	–	0.03%	229
2023 Q2	$233K	Hold	12,000	–	–	0.04%	215
2023 Q1	$340K	Hold	12,000	–	–	0.06%	190
2022 Q4	$351K	Hold	12,000	–	–	0.07%	175
2022 Q3	$317K	Hold	12,000	–	–	0.06%	183
2022 Q2	$533K	Sell	12,000 -12,000	-50%	-$533K	0.09%	192
2022 Q1	$1.19M	Hold	24,000	–	–	0.16%	166
2021 Q4	$1.22M	Hold	24,000	–	–	0.14%	180
2021 Q3	$1.34M	Hold	24,000	–	–	0.17%	169
2021 Q2	$1.03M	Hold	24,000	–	–	0.15%	184
2021 Q1	$1M	Hold	24,000	–	–	0.17%	175
2020 Q4	$1.12M	Buy	24,000 +12,000	+100%	+$559K	0.2%	160
2020 Q3	$510K	Sell	12,000 -12,000	-50%	-$510K	0.11%	180
2020 Q2	$1.15M	Hold	24,000	–	–	0.28%	98
2020 Q1	$1.1M	Hold	24,000	–	–	0.34%	82
2019 Q4	$1.44M	Hold	24,000	–	–	0.34%	90
2019 Q3	$1.36M	Hold	24,000	–	–	0.34%	89
2019 Q2	$1.34M	Hold	24,000	–	–	0.32%	92
2019 Q1	$1.21M	Hold	24,000	–	–	0.29%	99
2018 Q4	$967K	Hold	24,000	–	–	0.27%	113
2018 Q3	$1.66M	Hold	24,000	–	–	0.41%	81
2018 Q2	$1.82M	Hold	24,000	–	–	0.41%	76
2018 Q1	$1.27M	Hold	24,000	–	–	0.29%	100
2017 Q4	$1.28M	Hold	24,000	–	–	0.28%	99
2017 Q3	$1.43M	Hold	24,000	–	–	0.38%	85
2017 Q2	$1.89M	Hold	24,000	–	–	0.51%	71
2017 Q1	$1.99M	Hold	24,000	–	–	0.54%	55
2016 Q4	$1.9M	Hold	24,000	–	–	0.59%	53
2016 Q3	$1.68M	Hold	24,000	–	–	0.69%	24
2016 Q2	$931K	Hold	24,000	–	–	0.36%	99
2016 Q1	$972K	Hold	24,000	–	–	0.18%	116
2015 Q4	$2.13M	Hold	24,000	–	–	0.36%	88
2015 Q3	$1.78M	Hold	24,000	–	–	0.36%	81
2015 Q2	$1.94M	Hold	24,000	–	–	0.36%	87
2015 Q1	$1.01M	Sell	24,000 -108,790	-82%	-$4.56M	0.18%	135
2014 Q4	$2.06M	Hold	132,790	–	–	0.39%	82
2014 Q3	$1.68M	Buy	+132,790	New	+$1.68M	0.33%	94